Considerations for HAV vaccine in India.

作者: Prashant Mathur , Narendra K. Arora

DOI: 10.1007/BF02752368

关键词:

摘要: Currently available evidence indicates that most parts of India still qualify to be hyper-endemic regions and hence recommendations for vaccinations developed low endemicity are not applicable. There however, some pockets which showed distinct epidemiologic shift. is need identify geographic like Kerala have potential epidemic outbreaks through cyclic sero-epidemiological surveys. With economic development consequent improvements in the levels sanitation quality water supplies, more such areas will identified. Efforts improve personal hygiene remain as important efficient intervention retard transmission HAV. Unless a critical improvement living standards our population achieved, aim eradicating HAV infection from community realistic. Presently, cost three doses exorbitant focus vaccination restricted individual protection who likely unexposed till adulthood can afford pay it. below 5 years mostly asymptomatic. The use resources therefore offer vaccine high risk individuals beyond this age after screening antibodies against

参考文章(34)
Y. K. Joshi, B. M. Gandhi, B. N. Tandon, Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India. Bulletin of The World Health Organization. ,vol. 62, pp. 67- 73 ,(1984)
E B Keeffe, Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases The American Journal of Gastroenterology. ,vol. 90, pp. 201- 205 ,(1995)
F. E. Shaw, S. C. Hadler, J. E. Maynard, P. Konfortion, G. Law-Min, G. Brissonette, J. Ramphul, Hepatitis A in Mauritius: an apparent transition from endemic to epidemic transmission patterns. Annals of Tropical Medicine and Parasitology. ,vol. 83, pp. 179- 185 ,(1989) , 10.1080/00034983.1989.11812328
R. S. Gupta, J. Singh, D. C. Jain, D. Bora, C. Prakash, K. K. Datta, Epidemiology of endemic viral hepatitis in an urban area of India: a retrospective community study in Alwar. Bulletin of The World Health Organization. ,vol. 75, pp. 463- 468 ,(1997)
WAYNE M. LEDNAR, STANLEY M. LEMON, JAMES W. KIRKPATRICK, ROBERT R. REDFIELD, MIRIAM L. FIELDS, PATRICK W. KELLEY, FREQUENCY OF ILLNESS ASSOCIATED WITH EPIDEMIC HEPATITIS A VIRUS INFECTIONS IN ADULTS American Journal of Epidemiology. ,vol. 122, pp. 226- 233 ,(1985) , 10.1093/OXFORDJOURNALS.AJE.A114093
Craig N. Shapiro, Harold S. Margolis, Worldwide epidemiology of hepatitis A virus infection Journal of Hepatology. ,vol. 18, pp. S11- S14 ,(1993) , 10.1016/S0168-8278(05)80371-X
Harold S. Margolis, Will Hepatitis A Become a Vaccine-Preventable Disease? Annals of Internal Medicine. ,vol. 122, pp. 464- 465 ,(1995) , 10.7326/0003-4819-122-6-199503150-00011
Stephen C. Hadler, Hannah M. Webster, John J. Erben, Judith E. Swanson, James E. Maynard, Hepatitis A in Day-Care Centers New England Journal of Medicine. ,vol. 302, pp. 1222- 1227 ,(1980) , 10.1056/NEJM198005293022203
Anthea J. Tilzey, Sara J. Palmer, Susan Barrow, Keith R. Perry, Helen Tyrell, Assad Safary, Jangu E. Banatvala, Effect of hepatitis A vaccination schedules on immune response. Vaccine. ,vol. 10, ,(1992) , 10.1016/0264-410X(92)90563-Y
Wolfgang Jilg, Ruth Bittner, Hermann Schätzl, Rudolf Raßhofer, Marion Schmidt, Friedrich Deinhardt, The immune response to different doses of inactivated hepatitis A vaccine Journal of Hepatology. ,vol. 18, pp. S38- S40 ,(1993) , 10.1016/S0168-8278(05)80376-9